Skip to Main Content

Paper Details

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
BMJ
27
2023
Cannabidiol, Cannabis, cancer, cannabidiol, cannabinoids, cannabis, chronic pain, depression, diarrhoea, dizziness, dry mouth, epilepsy, gastrointestinal adverse events, human, impaired cognition, inflammatory bowel disease, low, mental health disorders, multiple sclerosis, nausea, pain, people, pneumonia, psychiatric, psychosis, psychotic symptoms, seizure, seizures, somnolence, spasticity, women
Author NameAffiliation
Eduard VietaInstitute of Neuroscience, Hospital Clinic, University of Barcelona
John P A IoannidisStanford University
John P A IoannidisBerlin Institute of Health, Charite Universitatsmedizin
John P A IoannidisStanford University
John P A IoannidisStanford University
John P A IoannidisBerlin Institute of Health, Charite Universitatsmedizin
John P A IoannidisStanford University
  • 1 - 7

Datasets

Dataset
Description
Source Link
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
Release 1.2